VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BRNX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BRNXBrenX Ltd.
$0.41$294411
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBRNXFinancials

BrenX Ltd. (BRNX) Income Statement

11Y historyFree accessUpdated daily

Revenue has been negligible at $193.5K in 2025 Q1 and Q2 versus $20.5K in 2023 Q3 and Q4, while cost of goods sold of $927.5K produced a gross margin of -3.8%, indicating BRNX is selling below direct production cost.

Income StatementBalance SheetCash FlowRatios

BRNX Income Statement

Annual statement

BRNX Income Statement

BrenX Ltd. (BRNX) annual income statement — 11-year revenue, gross profit & net income history

AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Sales/Revenue387K0621K1.52M395K092.9K0000
Revenue Growth %--100%-59.14%284.81%--100%-----
Cost of Goods Sold3.6M985K1.55M2.31M4.05M122K643.84K84.56K105.64K00
COGS % of Revenue929.2%-250.4%151.71%1025.57%-693.05%----
Gross Profit-3.21M-985K-934K-786K-3.66M-122K-550.94K-84.56K-105.64K00
Gross Margin %-829.2%--150.4%-51.71%-925.57%--593.05%----
Gross Profit Growth %-225.79%-5.46%-18.83%78.5%-2896.72%77.86%-551.57%19.96%---
Operating Expenses9.53M9.58M8.93M11.31M7.18M9.21M4.21M6.38M4.69M3.96M5.11M
OpEx % of Revenue2462.27%-1437.36%744.28%1817.47%-4530.21%----
Selling, General & Admin5.21M5.13M5.03M5.69M3M1.57M2.24M3.15M2.02M1.46M1.71M
SG&A % of Revenue1347.03%-809.18%374.14%758.99%-2408.16%----
Research & Development3.96M3.59M3.17M4.97M3.7M3.91M1.97M3.23M2.67M3.22M4.31M
R&D % of Revenue1023.26%-509.82%326.97%936.71%-2122.06%----
Other Operating Expenses356K858K735K656K481K3.73M0000-
Operating Income-12.74M-10.56M-9.86M-12.1M-11.96M-9.33M-4.76M-6.46M-4.8M-3.96M-5.11M
Operating Margin %-3291.47%--1587.76%-795.99%-3026.58%--5123.26%----
Operating Income Growth %-20.6%-7.12%18.51%-1.2%-28.13%-96.03%26.38%-34.75%-21.15%--
EBITDA-12.18M-10.33M-9.74M-11.86M-11.71M-8.65M-4.12M-6.38M-4.69M-3.79M-4.78M
EBITDA Margin %-3146.51%--1568.44%-780.26%-2963.29%--4433.53%----
EBITDA Growth %-17.83%-6.1%17.88%-1.32%-35.29%-110.07%35.44%-35.99%-23.83%--
D&A (Non-Cash Add-back)561K228K120K239K250K678K640.75K84.56K105.64K170.78K324.39K
EBIT-13.53M-6.53M-9.55M-11.42M-10.08M-9.1M-11.7M-6.88M-4.77M-3.96M-5.11M
Net Interest Income-299K-29K49K-58K-266K-371.62K-504.07K0000
Interest Income75K215K161K51K3K08428023.69M5.43M4.64M
Interest Expense374K244K112K109K269K372K504.91K000-
Other Income/Expense-1.17M3.79M212K1.03M-145K-144.76K-7.39M-726.51K-3.59M-5.43M-
Pretax Income-13.9M-6.77M-9.65M-11.07M-11.02M-9.47M-12.15M-7.19M-8.39M-9.39M-9.75M
Pretax Margin %-3593.02%--1553.62%-728.09%-2789.11%--13081.88%----
Income Tax00025K0001.67K-400
Effective Tax Rate %0%0%0%-0.23%0%0%0%-0.02%0%0%0%
Net Income-13.9M-6.77M-9.65M-11.07M-11.02M-9.48M-12.15M-7.19M-8.39M-9.39M-9.75M
Net Margin %-3593.02%--1553.62%-728.09%-2789.11%--13081.88%----
Net Income Growth %-105.33%29.81%12.82%-0.45%-16.2%21.99%-68.96%14.25%10.62%--
Net Income (Continuing)-13.9M-6.77M-9.65M-11.09M-11.02M-9.47M-12.15M-7.19M-8.39M-9.39M-9.75M
Discontinued Operations00000000000
Minority Interest00000000000
EPS (Diluted)-57.14-45.15-174.65-264.95-59.85-41.65-56.35-39.20-58.10-730.10-758.45
EPS Growth %-26.56%74.15%34.08%-342.69%-43.7%26.09%-43.75%32.53%92.04%--
EPS (Basic)-57.14-45.15-174.65-264.95-60.55-41.65-56.35-39.20-58.10-730.10-758.45
Diluted Shares Outstanding408.79K149.59K55.77K41.79K173.13K227.15K215.94K182.97K144.15K12.86K12.86K
Basic Shares Outstanding408.79K149.59K55.77K41.79K170.49K227.15K215.94K182.97K144.15K12.86K12.86K
Dividend Payout Ratio-----------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Persistent operating losses and negative gross profit

Revenue Base Too Thin to Assess Growth

Based on the reported quarterly figures, BRNX posted revenue of $193.5K in 2025 Q1 and Q2 against just $20.5K in 2023 Q3 and Q4, with no revenue reported in the most recent quarters.

The reported revenue series is so small and irregular that growth rates are not meaningful, and the absence of revenue in several recent quarters suggests the commercial model may not yet be generating repeatable sales. The apparent step-up in 2025 Q1 and Q2 is a single data point rather than an established trend. Investors should monitor whether revenue becomes recurring before attributing any durability to the top line.

Cost of Sales Exceeds Revenue Consistently

Reported cost of goods sold of $927.5K against revenue of $193.5K in 2025 Q1 and Q2 implies a gross margin of -3.8%, indicating the company is selling below its direct production cost.

Negative gross profit in every reported period, including -$870.5K in the latest quarters where revenue is unreported, points to unit economics that do not yet cover direct costs. This pattern is typical of early-stage manufacturing scale-up but suggests pricing power is absent at present. Gross margin improvement would need to come from either volume-driven cost absorption or a materially different cost base.

Fixed Overhead Dominates Operating Loss

Quarterly R&D of roughly $774K to $1.2M and SG&A of $1.3M to $1.5M together exceed $2M per quarter, which accounts for most of the reported operating loss of $2.3M to $3.3M.

Operating expenses are largely fixed and do not scale down with the revenue base, so the cost structure is dominated by overhead rather than production. Stock-based compensation of $186K to $457K per quarter also constitutes a meaningful share of spending that does not consume cash. Management's discipline is difficult to judge without a clear decline in these lines relative to revenue.

Share Count Dilution Distorts Per-Share Losses

Reported diluted EPS swings from -$8.05 to -$74.08 across quarters while net income ranges from -$790.5K to -$3.7M, suggesting share count changes or reverse splits are inflating per-share volatility.

The magnitude of EPS movement is disproportionate to the change in net loss, which warrants investigation into the underlying share count and any corporate actions affecting comparability. Negative EPS growth of -4.7% to -7.3% alongside wider loss figures indicates the per-share metric is not a reliable gauge of progress here. Analysts should reconcile reported EPS against net income and share data before relying on it.

Persistent Losses Without Demonstrated Path

Every reported quarter shows an operating loss between $2.3M and $3.3M and negative gross profit, with no quarter in the dataset showing a sign of profitability or breakeven.

The bear case centers on the absence of any period in which gross profit turned positive, which would suggest the business model may require scale or pricing changes that are not visible in these figures. Net margins as low as -112.1% against negligible revenue imply the company depends on external capital to fund operations, though the supplied data does not disclose financing terms. Investors should treat the income statement as showing no demonstrated path to profitability until gross margin turns positive.

BRNX — Frequently Asked Questions

Quick answers to the most common questions about buying BRNX stock.

What was BrenX Ltd.'s (BRNX) revenue in 2025?

For fiscal year 2025, BrenX Ltd. (BRNX) reported total revenue of $0.4M.

Is BrenX Ltd. (BRNX) profitable?

BrenX Ltd. (BRNX) reported a net loss of $13.9M for the fiscal year ending 2025.

What is BrenX Ltd.'s operating profit margin?

BrenX Ltd. (BRNX) reported an operating income of $-12.7M, resulting in an operating profit margin of -3291.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is BrenX Ltd.'s gross profit and gross margin?

BrenX Ltd. (BRNX) generated $-3.2M in gross profit for the year, representing a gross profit margin of -829.2%. This demonstrates the company's core pricing power and production efficiency.